FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$2.45 B | $2.91 B | $3.62 B | $4.03 B | $4.66 B | $4.82 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$768.00 M | $1.03 B | $1.33 B | $1.59 B | $1.86 B | $1.84 B |
Gross Profit Revenue minus cost of revenue. |
|
$1.68 B | $1.88 B | $2.29 B | $2.44 B | $2.80 B | $2.98 B |
|
Operating Expense
Costs to run business. 
|
|
$1.41 B | $1.49 B | $1.69 B | $1.84 B | $1.89 B | $1.95 B |
Operating Income Profit from operations. |
|
$265.80 M | $391.20 M | $597.70 M | $600.00 M | $911.80 M | $1.03 B |
|
Net Interest Income
Interest income minus expense.
|
|
-$17.10 M | $5.20 M | $114.70 M | $115.20 M | - | $70.60 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$9.80 M | -$18.20 M | -$133.00 M | -$128.00 M | - | - |
Total Other Income (Net) Net non-operating items. |
|
-$9.00 M | -$400.00 K | $112.70 M | $109.00 M | $176.60 M | $170.20 M |
Income Before Tax Profit before taxes. |
|
$256.80 M | $390.80 M | $710.40 M | $709.00 M | $1.09 B | $1.20 B |
Income Tax Expense Taxes on income. |
|
$39.90 M | $49.60 M | $168.90 M | $132.80 M | $252.10 M | $273.20 M |
|
Net Income
Final profit.
|
|
$216.90 M | $341.20 M | $541.50 M | $576.20 M | $836.30 M | $930.40 M |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$0.56 | $0.88 | $1.44 | $1.46 | $2.14 | $2.40 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$0.51 | $0.80 | $1.30 | $1.42 | $2.09 | $2.34 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
386.90 M | 389.40 M | 386.00 M | 404.63 M | 390.20 M | 385.10 M |
Diluted Average Shares Outst. Shares including dilution. |
|
428.80 M | 427.50 M | 425.50 M | 412.70 M | 405.50 M | 393.60 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$275.60 M | $409.40 M | $730.70 M | $728.00 M | $911.80 M | $1.03 B |
EBITDA Earnings before interest, tax, D&A. |
|
$377.50 M | $565.30 M | $916.70 M | $945.70 M | $1.16 B | $1.29 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$101.90 M | $155.90 M | $186.00 M | $217.70 M | $251.80 M | $258.90 M |
| Company Report |
FY 2025
DexCom's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
DexCom's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
DexCom's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
DexCom's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
